ClinicalTrials.gg
CompletedNCT05039528Updated Oct 2, 2026Results posted

Design and Usability Testing of a Tailored Intervention About Sleep and Sleep Disorders Among Transportation Workers

An interventional study of Personalized OSA messages and Control in Obstructive Sleep Apnea, sponsored by Brigham and Women's Hospital. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Supportive care

How we know · 2 judgments

Updated Oct 2, 2026Results postedStudy documents posted+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 42 studies in Sleep Apnea, Obstructive by Brigham and Women's Hospital — 12 open to participants now, 12 under way, none of them phase 3. Sleep Apnea, Obstructive · Brigham and Women's Hospital.

Enrollment
14th of 42
38 · median 22
Started
2022
with 2 others
No phase
19 of 42
3 open now
Registered
30th of 42
by date

Among the 42 studies in Sleep Apnea, Obstructive by Brigham and Women's Hospital, this one is the 14th largest by enrollment, is one of 3 that started in 2022, is one of 19 with no phase, and was the 30th registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

12 of the 42 studies in Sleep Apnea, Obstructive by Brigham and Women's Hospital are open now, in 1 country. Recruiting first, the newest first:

7 more — sign in →

By country, each count listing its studies:

All 12 open studies →

Where they have run

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Sleep Apnea, Obstructive by Brigham and Women's Hospital, or all of them as a file.
02

Study summary

The objective of this protocol is to conduct a focus group to identify OSA beliefs, attitudes, and knowledge among employees in the transportation industry on shift schedules.

Read the detailed description

Transportation shift workers (TSW, e.g., overnight, on-call, or rotating) have been identified as a high-risk group for health conditions (e.g., obesity, cardiovascular disease). Also, TSW are at risk for obstructive sleep apnea (OSA). According to one study, approximately 36% of TSWs have OSA, a condition that exacerbates health risks and daytime sleepiness. A recent report from the American Academy of Sleep Medicine (AASM) showed that those with untreated OSA cost on average $4,261 more than those without OSA. Also concerning, workers with OSA who are non-adherent to recommended OSA treatment (i.e., continuous positive airway pressure, CPAP) are at particularly high risk for motor vehicle accidents compared to those who are adherent.

This protocol outlines focus groups that will aim to identify knowledge, attitudes, and beliefs about OSA among TSW. Results of these focus groups will be used in future research to design a tailored website for relaying OSA information to TSW.

03

Conditions studied

  • Obstructive Sleep Apnea
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18 years or older
  2. Access to a smartphone device
  3. Commitment to completing all study activities
  4. Score 4 or higher (mild or higher on OSA risk) according to the Apnea Risk Evaluation System (ARES) questionnaire.

Exclusion criteria

Exclusion Criteria:

  1. Significant medical or psychiatric illness according to the PROMIS Short Form (SF-12)
  2. No OSA risk (a score below 4 on the ARES).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    Intervention

    Participants will receive the personalized OSA messages.

    Behavioral: Personalized OSA messages

  • Placebo comparator
    Control

    Placebo participants will receive no treatment during the experiment.

    Other: Control

Interventions

  • BehavioralPersonalized OSA messages

    Participants will receive personalized OSA messages designed to nudge and navigate them toward evaluation and treatment for OSA. Participants will complete questionnaires at baseline and at study follow-up.

  • OtherControl

    Participants will complete questionnaires at baseline and at study follow-up. At the end of the study period, participants will receive the OSA message intervention.

06

What researchers measure

Primary outcomes

  1. Obstructive Sleep Apnea (OSA) Self-efficacy

    The Survey of Obstructive Sleep Apnea Functional Health Literacy (SOFHL) was administered, which includes two subscales, one for OSA Self-Efficacy and another for OSA Knowledge. The SOFHL can be scored by measuring the proportion of correct answers in each sub-scale (OSA Self-Efficacy and OSA Knowledge). The OSA Self-Efficacy subscale collects responses to 5 self-efficacy questions on 3-point scales from 1 "I am confident" to 2 "I am not sure" and 3 "I am not confident." Scores of 1 ("I am confident") indicate self-efficacy. To score OSA Self-Efficacy, the total number of questions that participants mark a response of "1" ("I am confident") are summed then divided by the total number of questions in the subscale (5) and multiplied by 100. The result is a total score with a minimum possible value of 0% and a maximum possible value of 100%. Lower scores (closer to 0%) indicate low OSA self-efficacy scores. Higher scores (closer to 100%) indicate higher OSA Self-efficacy.

    Time frame: Baseline and follow-up (approximately 2 months)

Secondary outcomes

  1. OSA Knowledge

    The Survey of Obstructive Sleep Apnea Functional Health Literacy (SOFHL) was administered, which includes two subscales, one for OSA Self-Efficacy and another for OSA Knowledge. The SOFHL can be scored by measuring the proportion of correct answers in each sub-scale (OSA Self-Efficacy and OSA Knowledge). The OSA Knowledge subscale collects responses to 13 knowledge questions on 3-point scale from 1 ("I am confident this is true") to 2 ("I am not sure") and 3 ("I am confident this is not true"). To score OSA Knowledge, the total number of responses of 1 "I am confident this is true" are summed then divided by 13 and multiplied by 100. The result is a score with a minimum possible value of 0% and a maximum possible value of 100%. Lower scores (closer to 0%) indicate lower OSA knowledge while higher scores (closer to 100%) indicate higher OSA Knowledge.

    Time frame: Baseline and follow-up (approximately 2 months)

  2. OSA Readiness to Change

    OSA Readiness to Change: A measure of willingness to improve sleep and address sleep problems. OSA readiness to change will be measured with a 12-item questionnaire. Responses are captured on a 5-item scale from 1 "strongly disagree" to 5 "strongly agree." Responses are summed for a total score of readiness to change. Higher scores indicate higher levels of readiness to change.

    Time frame: Baseline and follow-up (approximately 2 months)

07

Results

Posted Oct 2, 2026

Participant flow

Participants (n=38) were randomized at the worksite level to intervention (n=18) or control (n=20).

Participant flow — Overall Study
MilestoneInterventionControl
Started1820
Completed1820
Not completed00

Outcome measures

PrimaryObstructive Sleep Apnea (OSA) Self-efficacy

The Survey of Obstructive Sleep Apnea Functional Health Literacy (SOFHL) was administered, which includes two subscales, one for OSA Self-Efficacy and another for OSA Knowledge. The SOFHL can be scored by measuring the proportion of correct answers in each sub-scale (OSA Self-Efficacy and OSA Knowledge). The OSA Self-Efficacy subscale collects responses to 5 self-efficacy questions on 3-point scales from 1 "I am confident" to 2 "I am not sure" and 3 "I am not confident." Scores of 1 ("I am confident") indicate self-efficacy. To score OSA Self-Efficacy, the total number of questions that participants mark a response of "1" ("I am confident") are summed then divided by the total number of questions in the subscale (5) and multiplied by 100. The result is a total score with a minimum possible value of 0% and a maximum possible value of 100%. Lower scores (closer to 0%) indicate low OSA self-efficacy scores. Higher scores (closer to 100%) indicate higher OSA Self-efficacy.

Time frame:
Baseline and follow-up (approximately 2 months)
Reported as:
Mean · Scores on a scale
Obstructive Sleep Apnea (OSA) Self-efficacy
Scores on a scaleInterventionControl
Baseline53.3 ± 24.747.0 ± 31.1
Follow up56.7 ± 29.343.5 ± 32.6
SecondaryOSA Knowledge

The Survey of Obstructive Sleep Apnea Functional Health Literacy (SOFHL) was administered, which includes two subscales, one for OSA Self-Efficacy and another for OSA Knowledge. The SOFHL can be scored by measuring the proportion of correct answers in each sub-scale (OSA Self-Efficacy and OSA Knowledge). The OSA Knowledge subscale collects responses to 13 knowledge questions on 3-point scale from 1 ("I am confident this is true") to 2 ("I am not sure") and 3 ("I am confident this is not true"). To score OSA Knowledge, the total number of responses of 1 "I am confident this is true" are summed then divided by 13 and multiplied by 100. The result is a score with a minimum possible value of 0% and a maximum possible value of 100%. Lower scores (closer to 0%) indicate lower OSA knowledge while higher scores (closer to 100%) indicate higher OSA Knowledge.

Time frame:
Baseline and follow-up (approximately 2 months)
Reported as:
Mean · Scores on a scale
OSA Knowledge
Scores on a scaleInterventionControl
Baseline42.7 ± 18.349.2 ± 26.3
Follow up (2 months)58.3 ± 21.650.7 ± 25.1
SecondaryOSA Readiness to Change

OSA Readiness to Change: A measure of willingness to improve sleep and address sleep problems. OSA readiness to change will be measured with a 12-item questionnaire. Responses are captured on a 5-item scale from 1 "strongly disagree" to 5 "strongly agree." Responses are summed for a total score of readiness to change. Higher scores indicate higher levels of readiness to change.

Time frame:
Baseline and follow-up (approximately 2 months)
Reported as:
Mean · Scores on a scale
OSA Readiness to Change
Scores on a scaleInterventionControl
Baseline6.2 ± 2.16.7 ± 1.9
Follow up (2 months)7.2 ± 1.36.6 ± 2.6

Adverse events

Collected over Baseline to 2 months follow-up. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention0/18 (0%)0/18 (0%)0/18 (0%)
Control0/20 (0%)0/20 (0%)0/20 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Age, years)InterventionControlTotal
Mean43.9 ± 12.0142.8 ± 12.543.4 ± 12.1
Sex: Female, Male
Sex: Female, Male(Participants)InterventionControlTotal
Female505
Male132033
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)InterventionControlTotal
White/non-Hipsanic181735
Other022
Did not respond011
OSA Self-Efficacy
OSA Self-Efficacy(Scores on a scale)InterventionControlTotal
Mean53.5 ± 24.747.0 ± 31.350 ± 28.1
OSA Knowledge
OSA Knowledge(Scores on a scale)InterventionControlTotal
Mean42.7 ± 18.049.2 ± 26.345.3 ± 22.4
OSA Readiness to Change
OSA Readiness to Change(Scores on a scale)InterventionControlTotal
Mean6.2 ± 2.16.7 ± 1.96.4 ± 2.0
08

Study locations

1 site
  • Brigham and Women's Hospital
    Boston, Massachusetts 02115, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2022 to primary completion in Jul 2024, 21 months.

Results were first posted in Oct 2026, 2 years 3 months after primary completion.

Of 511 non-industry interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 21 months is below that.

Counting every sponsor, half of 629 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 12, 2021
First posted
Sep 9, 2021
StartActual
Oct 1, 2022
Primary completionActual
Jul 1, 2024
CompletionActual
Jul 1, 2024
Results first posted
Oct 2, 2026
Last update
Oct 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 2, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Change in OSA self-management efficacy as measured by the Survey of OSA Functional Health Literacy (SOFHL)Now Obstructive Sleep Apnea (OSA) Self-efficacyTime frame: The SOFHL will be administered at baseline and post-intervention. Change in SOFHL score on self-management efficacy will be computed by comparing responses at baseline and post-intervention. → Baseline and follow-up (approximately 2 months)
Oct 2, 2026
Documents
Secondary outcomes
2 added, 3 removed
What changed in the outcomes
  • AddedOSA KnowledgeTime frame: Baseline and follow-up (approximately 2 months)
  • AddedOSA Readiness to ChangeTime frame: Baseline and follow-up (approximately 2 months)
  • RemovedChange in OSA general knowledge as measured by the SOFHL.Time frame: The SOFHL will be administered at baseline and post-intervention. Change in SOFHL score on OSA general knowledge will be computed by comparing responses at baseline and post-intervention.
  • RemovedChange in Daytime sleepiness as measured by the Epworth Sleepiness Scale (ESS).Time frame: Sleepiness will be assessed at baseline and post-intervention. Change in daytime sleepiness will be computed by comparing responses at baseline and post-intervention..
  • RemovedChange in Attentional Failures as measured by previously validated questions assessing Attentional Failures.Time frame: Attentional failures will be measured at baseline and post-intervention.Change in attentional failures will be computed by comparing responses at baseline and follow-up.
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    Results posted
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Change in OSA self-management efficacy as measured by the Survey of OSA Functional Health Literacy (SOFHL)Now Obstructive Sleep Apnea (OSA) Self-efficacyTime frame: The SOFHL will be administered at baseline and post-intervention. Change in SOFHL score on self-management efficacy will be computed by comparing responses at baseline and post-intervention. → Baseline and follow-up (approximately 2 months)
    Secondary outcomes 2 added, 3 removed
    What changed in the outcomes
    • AddedOSA KnowledgeTime frame: Baseline and follow-up (approximately 2 months)
    • AddedOSA Readiness to ChangeTime frame: Baseline and follow-up (approximately 2 months)
    • RemovedChange in OSA general knowledge as measured by the SOFHL.Time frame: The SOFHL will be administered at baseline and post-intervention. Change in SOFHL score on OSA general knowledge will be computed by comparing responses at baseline and post-intervention.
    • RemovedChange in Daytime sleepiness as measured by the Epworth Sleepiness Scale (ESS).Time frame: Sleepiness will be assessed at baseline and post-intervention. Change in daytime sleepiness will be computed by comparing responses at baseline and post-intervention..
    • RemovedChange in Attentional Failures as measured by previously validated questions assessing Attentional Failures.Time frame: Attentional failures will be measured at baseline and post-intervention.Change in attentional failures will be computed by comparing responses at baseline and follow-up.
    + 2 other changes: index terms and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05039528
Responsible party
Rebecca Robbins (Assistant Professor of Medicine at Harvard Medical Scool and Associate Scientist at Brigham & Women's Hospital, Brigham and Women's Hospital) — Principal investigator
First posted
Sep 9, 2021
Start date
Oct 1, 2022
Primary completion
Jul 1, 2024
Completion
Jul 1, 2024
Results posted
Oct 2, 2026
Last update
Oct 2, 2026

Study contacts

Rebecca Robbins, PhD
principal investigator · Brigham and Women's Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion